Certara, Inc. (CERT), a commercial-stage drug development services company, announced on Wednesday that current Chief Financial Officer, John Gallagher, will resign on July 14, 2026.
Gallagher previously notified the company of his intention to resign from his office.
The company will appoint Faiz Mohammed as interim Chief Financial Officer until a permanent successor is named. Mohammed currently serves as Certara's Senior Vice President of Finance and Treasurer.
Mohammed brings more than 25 years of experience as a senior finance and accounting executive across public and private equity-backed companies.
Certara shares closed Wednesday at $6.03, down 0.33%. In the overnight market, shares are trading at $5.88, down 2.49%.
For more such biotech stock news, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.